Down-regulation of PKHD1 induces cell apoptosis through PI3K and NF-κB pathways

Experimental Cell Research

Volumn 317, Issue 7, 2011, Pages 932-940

  Sun, Liping ^a   Wang, Shixuan ^b   Hu, Chaofeng ^c   Zhang, Xinzhou ^a  

^a JINAN UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; LY294002; NF B; PI3K Akt pathway; PKHD1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; FIBROCYSTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; KIDNEY CELL; PRIORITY JOURNAL;

EID: 79952449303     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.01.025     Document Type: Article

References (31)

1. Guay-Woodford L.M. Autosomal recessive PKD in the early years. Nephrol News Issues 2007, 21:39.
2. Gunay-Aygun M., Avner E.D., Bacallao R.L., Choyke P.L., Flynn J.T., Germino G.G., Guay-Woodford L., Harris P., Heller T., Ingelfinger J., Kaskel F., Kleta R., LaRusso N.F., Mohan P., Pazour G.J., Shneider B.L., Torres V.E., Wilson P., Zak C., Zhou J., Gahl W.A. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J. Pediatr. 2006, 149:159-164.
3. Wang S., Zhang J., Nauli S.M., Li X., Starremans P.G., Luo Y., Roberts K.A., Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol. Cell. Biol. 2007, 27:3241-3252.
4. Ward C.J., Hogan M.C., Rossetti S., Walker D., Sneddon T., Wang X., Kubly V., Cunningham J.M., Bacallao R., Ishibashi M., Milliner D.S., Torres V.E., Harris P.C. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 2002, 30:259-269.
5. Onuchic L.F., Furu L., Nagasawa Y., Hou X., Eggermann T., Ren Z., Bergmann C., Senderek J., Esquivel E., Zeltner R., Rudnik-Schoneborn S., Mrug M., Sweeney W., Avner E.D., Zerres K., Guay-Woodford L.M., Somlo S., Germino G.G. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 2002, 70:1305-1317.
6. Harris P.C., Torres V.E. Polycystic kidney disease. Annu Rev. Med. 2009, 60:321-337.
7. Jr Sweeney W.E., Avner E.D. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res. 2006, 326:671-685.
8. Elis W., Lessmann E., Oelgeschlager M., Huber M. Mutations in the inter-SH2 domain of the regulatory subunit of phosphoinositide 3-kinase: effects on catalytic subunit binding and holoenzyme function. Biol. Chem. 2006, 387:1567-1573.
9. Geering B., Cutillas P.R., Vanhaesebroeck B. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits. Biochem. Soc. Trans. 2007, 35:199-203.
10. Sellers L.A., Alderton F., Carruthers A.M., Schindler M., Humphrey P.P. Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways. Mol. Cell. Biol. 2000, 20:5974-5985.
11. Ku K.T., Huang Y.L., Huang Y.J., Chiou W.F. Miyabenol A inhibits LPS-induced NO production via IKK/IkappaB inactivation in RAW 264.7 macrophages: possible involvement of the p38 and PI3K pathways. J. Agric. Food Chem. 2008, 56:8911-8918.
12. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal. 2002, 14:381-395.
13. Shen H.M., Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
14. Grimm S., Bauer M.K., Baeuerle P.A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 1996, 134:13-23.
15. Zheng R., Wang L., Fan J., Zhou Q. Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway. Cell Biol. Int. 2009, 33:926-933.
16. Franke T.F. PI3K/Akt: getting it right matters. Oncogene 2008, 27:6473-6488.
17. White M.K., Strayer D.S. Survival signaling in type II pneumocytes activated by surfactant protein-A. Exp Cell Res. 2002, 280:270-279.
18. Goilav B., Satlin L.M., Wilson P.D. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases. Pediatr. Nephrol. 2008, 23:1473-1482.
19. Nagano J., Kitamura K., Hujer K.M., Ward C.J., Bram R.J., Hopfer U., Tomita K., Huang C., Miller R.T. Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling. Biochem. Biophys. Res. Commun. 2005, 338:880-889.
20. Gonzalez-Garcia A., Garrido E., Hernandez C., Alvarez B., Jimenez C., Cantrell D.A., Pullen N., Carrera A.C. A new role for the p85-phosphatidylinositol 3-kinase regulatory subunit linking FRAP to p70 S6 kinase activation. J. Biol. Chem. 2002, 277:1500-1508.
21. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
22. Javadov S., Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007, 20:1-22.
23. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347.
24. Dieguez-Acuna F.J., Polk W.W., Ellis M.E., Simmonds P.L., Kushleika J.V., Woods J.S. Nuclear factor kappaB activity determines the sensitivity of kidney epithelial cells to apoptosis: implications for mercury-induced renal failure. Toxicol Sci. 2004, 82:114-123.
25. Bandyopadhaya A., Das D., Chaudhuri K. Involvement of intracellular signaling cascades in inflammatory responses in human intestinal epithelial cells following Vibrio cholerae infection. Mol. Immunol. 2009, 46:1129-1139.
26. Sasaki C.Y., Barberi T.J., Ghosh P., Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J. Biol. Chem. 2005, 280:34538-34547.
27. Pengal R.A., Ganesan L.P., Wei G., Fang H., Ostrowski M.C., Tridandapani S. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol. Immunol. 2006, 43:1557-1564.
28. Guzik T.J., Harrison D.G. Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease?. Circ. Res. 2007, 101:227-229.
29. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000, 404:892-897.
30. Clark J.A., Coopersmith C.M. Just the right amount of JNK - how NF-κB and downstream mediators prevent burn-induced intestinal injury. Crit Care Med. 2007, 1433-1434.
31. Mattioli B., Giordani L., Quaranta M.G., Viora M. Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Lett. 2009, 583:1102-1106.